Key facts
| Legal name | Strive Pharmacy LLC (Gilbert, AZ); Strive Pharmacy Texas LLC (Boerne, TX) |
|---|---|
| Location | 1275 E Baseline Rd #104, Gilbert, AZ 85233; seven locations claimed |
| Type | 503A compounding pharmacy |
| On FDA 503B list | No |
| Accreditations it claims | NABP accredited, PCAB (ACHC) at some locations, LegitScript — not independently verified |
| States | Says "50 States licensed in"; its provider-finder lists 42 states plus DC and Puerto Rico |
| GLP-1 products it lists | Tirzepatide/glycine/B12 and semaglutide/glycine/B12 injections |
| FDA record | Form 483, Boerne TX, Sept 8, 2023; warning letter 639220 (Aug 29, 2022) closed out May 13, 2026 |
| State board | Arizona Board of Pharmacy consent agreement Feb 7, 2024 ($1,000 fine), as reported by Sherwood News |
| Litigation | Lilly v. Strive (D. Del.) dismissed Oct 8, 2025; Strive's antitrust suit against Lilly and Novo dismissed (Reuters, Aug 6, 2026) |
Regulatory record
FDA issued a Form 483 to the Boerne, Texas site on September 8, 2023. The Arizona Board of Pharmacy entered a consent agreement with a $1,000 fine on February 7, 2024, as reported by Sherwood News.
Litigation
Lilly’s suit against Strive in Delaware was dismissed on October 8, 2025 for lack of personal jurisdiction. Strive’s own antitrust suit against Lilly and Novo was dismissed, Reuters reported on August 6, 2026.
How to check any compounding pharmacy
Read the pharmacy name on your vial label, look it up with the board of pharmacy in your state, check FDA’s outsourcing-facility list if it claims 503B status, and search FDA’s warning-letter database by name. Our 503A vs 503B guide explains the difference.
Questions about Strive Pharmacy
Does Strive add B12 to semaglutide?
Yes. It lists semaglutide/glycine/B12. FDA’s April 1, 2026 policy treats semaglutide-plus-B12 products near an approved strength as possible copies, so ask your prescriber why the additive is there.
Is Strive licensed in all 50 states?
It says so, but its provider finder lists 42 states plus DC and Puerto Rico.
Sources
A Form 483 records an inspector’s observations and is not a final agency finding. Compounded drugs are not FDA-approved. This profile is informational and is not an endorsement.